Substances · Benzodiazepines and thienodiazepines
Flubromazepam
- Preferred name
- Flubromazepam
- IUPAC name
- 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
- Parent CAS number (reference)
- 2647-50-9
- Molecular formula
- C15H10BrFN2O
- Molecular weight
- 333.15 g/mol
- InChIKey
- ZRKDDZBVSZLOFS-UHFFFAOYSA-N
- PubChem
- CID 12947024
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Ro 05-2904 7-Bromo-2'-fluorodesmethyldiazepam
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
Flubromazepam
Receptor Telemetry & Mechanism of Action
7-Bromo-2'-fluoro-1,4-benzodiazepin-2-one acting as a classic full GABA-A PAM with an elimination half-life exceeding 100 hours in human pharmacokinetic studies.
Biotransformation & Active Metabolites
Human pharmacokinetic study (Moosmann et al.) documents a ~106-hour terminal half-life via monohydroxylated metabolites.
Temporal Pharmacokinetics
Ultra-Long Half-Life GABA-A PAM — Lower milligram potency per 1 mg tablet (common literature range 4–8 mg), but extreme ~106 h half-life means slow onset (up to 2 h) and severe multi-day accumulation hazard if repeated before clearance.
- Onset 45–120 min
- Peak Window 3–6 h
- Total Window 12–24 h
- Residual / Half-Life 36–72+ h residual (T1/2 ~106 h)
Lower milligram potency per 1 mg tablet (common literature range 4–8 mg), but extreme ~106 h half-life means slow onset (up to 2 h) and severe multi-day accumulation hazard if repeated before clearance.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
2 mg
Subtle threshold receptor activity (Ultra-Long Half-Life GABA-A PAM).
Minimal baseline autonomic shift.
2–4 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
4–8 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
8–12 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
14+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Synergistic brainstem respiratory depression causing unconsciousness and fatal respiratory arrest.
Extreme CNS depression, complete anterograde amnesia, loss of airway reflexes, and fatal aspiration.
Elevated Hazard — Avoid
Unpredictable sedation, severe motor ataxia, blackout, and emesis aspiration hazard.
Caution / Receptor Attenuation
CYP3A4 inhibitors prolong plasma half-life; stimulants mask sedation until they wear off.
Structural Isomer & Sibling Comparison
Lower milligram potency per 1 mg tablet (common literature range 4–8 mg), but extreme ~106 h half-life means slow onset (up to 2 h) and severe multi-day accumulation hazard if repeated before clearance.
Physicochemical Stability & Storage
Form: Precision-pressed 1 mg analytical tablets (1 tablet = 1 mg). · Parent molecule soluble in ethanol, propylene glycol, and DMSO; sparingly soluble in water.
Store sealed in a cool, dry, light-protected container away from humidity.
Cross-Tolerance & Dependence Profile
Complete cross-tolerance across all GABA-A benzodiazepines/thienodiazepines. Rapid physical dependence develops with continuous daily exposure; abrupt cessation after prolonged intake can trigger life-threatening rebound seizures and delirium.
Chemical Architecture & Structural Profile
Flubromazepam (7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one) is a reference compound belonging to the Benzodiazepines and thienodiazepines class, characterized by the molecular formula C15H10BrFN2O and a molar mass of 333.15 g/mol. The parent molecule is indexed under CAS registry number 2647-50-9 and in the NCBI PubChem database as CID 12947024 (Standard InChIKey: ZRKDDZBVSZLOFS-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), Flubromazepam is indexed within the Benzodiazepines structural group. Toxicological notes (PsychonautWiki): low toxicity, potentially lethal when mixed with depressants like alcohol or opioids. Dependence liability (PsychonautWiki): extremely physically and psychologically addictive. Documented cross-tolerance class: benzodiazepines. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- legislation.gov.uk — Misuse of Drugs Act 1971 & Psychoactive Substances Act 2016 — The National Archives (UK) (2026-11-12)